Amy Kruse

Dr. Amy Kruse is General Partner and Chief Investment Officer at Satori Neuro, a venture fund dedicated to transformative solutions in mental health, neurotechnology, and human flourishing. A seasoned neuroscientist, investor, and technology leader, Amy previously served as General Partner at Prime Movers Lab, focusing on human augmentation and longevity. She actively contributes her expertise as a trusted board member for multiple companies across both venture portfolios. Earlier, she was Chief Scientific Officer at Optios and Vice President and Chief Technology Officer at Cubic Global Defense, guiding advanced R&D programs. At DARPA, Amy pioneered performance-oriented neuroscience initiatives. A recognized thought leader, Amy advises NIH’s Blueprint MedTech, BrainMind, Capital Factory, and mentors for the OneMind Accelerator. She frequently contributes to DARPA, National Academies, and Defense Science Board advisory panels. Amy holds a BS and PhD in Neuroscience from the University of Illinois Urbana-Champaign, supported by a National Science Foundation Graduate Fellowship.